Post Tagged with: "Eculizumab"

Editor’s Pick: Complement Pathway Associated Glomerulopathies

Editor’s Pick: Complement Pathway Associated Glomerulopathies

European Medical Journal, Nephrology January 26, 2016 at 9:07 AM 0 comments

Our understanding of pathophysiology across the continuum of renal diseases is rapidly increasing, not only in terms of rare renal disease, but also in relation to more common diseases. Complement activation is associated with a wide number of kidney disorders, and recent advances in this area of research mean thatRead More

Treatment of Antibody-Mediated Rejection in Kidney Transplantation

Treatment of Antibody-Mediated Rejection in Kidney Transplantation

Nephrology December 30, 2013 at 6:38 AM 0 comments

Magdalena Durlik Department of Transplantation Medicine and Nephrology, Warsaw Medical University, Warsaw, Poland Disclosure: No potential conflict of interest. Citation: EMJ Neph. 2013;1:40-45. Abstract Antibody-mediated rejection (AMR) is a relatively rare but severe complication in kidney transplantation associated with increased risk of graft loss. Diagnosis of acute and chronic AMRRead More

Delayed Erythroid and Platelet Response to Eculizumab in Paroxysmal Nocturnal Haemoglobinuria – A Case Report and Literature Review

Delayed Erythroid and Platelet Response to Eculizumab in Paroxysmal Nocturnal Haemoglobinuria – A Case Report and Literature Review

Hematology December 29, 2013 at 2:18 AM 0 comments

Andres L. Brodsky, Laura B. Colin Hospital de Clinicas ‘Jose de San Martin’, Hematology Division, Department of Medicine, University of Buenos Aires, Argentina Disclosure: No potential conflict of interest. Citation: EMJ Hema. 2013;1:20-24. Abstract Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired clonal disorder of haemopoiesis characterised by haemolytic anaemia, thrombophiliaRead More